doi: 10.1210/en.2004-0733 Summary Keywords fibroblasts, melanocortin, drug development, resolution of inflammation, fibrosis Citation Khodeneva N, Sugimoto MA, Davan-Wetton CSA and Montero-Melendez T (2023) Melanocortin therapies to resolve fibroblast-mediated diseases
When in doubt, your Ethos provider will guide your treatment calendar to balance effectiveness with safety, never rushing the process at the expense of your skin health
You can read more about the safety profile in the AOD 9604 side effects article
In: New England Journal of Medicine
Cardiovascular risk and obesity
This is why Wegovy and Hashimoto are often discussed together, as Wegovy may support weight loss in eligible individuals while standard thyroid treatment continues to manage the underlying autoimmune condition under medical supervision